147 related articles for article (PubMed ID: 25602109)
1. Antibody-drug conjugate for advanced melanoma?
Sharma SP
Lancet Oncol; 2014 Nov; 15(12):e534. PubMed ID: 25602109
[No Abstract] [Full Text] [Related]
2. An antibody-drug conjugate targeting the endothelin B receptor for the treatment of melanoma.
Asundi J; Reed C; Arca J; McCutcheon K; Ferrando R; Clark S; Luis E; Tien J; Firestein R; Polakis P
Clin Cancer Res; 2011 Mar; 17(5):965-75. PubMed ID: 21245091
[TBL] [Abstract][Full Text] [Related]
3. Tremelimumab (CP-675,206), a cytotoxic T lymphocyte associated antigen 4 blocking monoclonal antibody in clinical development for patients with cancer.
Ribas A; Hanson DC; Noe DA; Millham R; Guyot DJ; Bernstein SH; Canniff PC; Sharma A; Gomez-Navarro J
Oncologist; 2007 Jul; 12(7):873-83. PubMed ID: 17673618
[TBL] [Abstract][Full Text] [Related]
4. CR011, a fully human monoclonal antibody-auristatin E conjugate, for the treatment of melanoma.
Tse KF; Jeffers M; Pollack VA; McCabe DA; Shadish ML; Khramtsov NV; Hackett CS; Shenoy SG; Kuang B; Boldog FL; MacDougall JR; Rastelli L; Herrmann J; Gallo M; Gazit-Bornstein G; Senter PD; Meyer DL; Lichenstein HS; LaRochelle WJ
Clin Cancer Res; 2006 Feb; 12(4):1373-82. PubMed ID: 16489096
[TBL] [Abstract][Full Text] [Related]
5. Integration of monoclonal antibodies and immunoconjugates into the treatment of acute myeloid leukemia.
Amadori S; Stasi R
Curr Opin Hematol; 2008 Mar; 15(2):95-100. PubMed ID: 18300754
[TBL] [Abstract][Full Text] [Related]
6. The use of monoclonal antibody immunoconjugates in cancer therapy.
Pietersz GA; Krauer K; McKenzie IF
Adv Exp Med Biol; 1994; 353():169-79. PubMed ID: 7985535
[No Abstract] [Full Text] [Related]
7. Advancing antibody drug conjugation: from the laboratory to a clinically approved anticancer drug.
Okeley NM; Alley SC; Senter PD
Hematol Oncol Clin North Am; 2014 Feb; 28(1):13-25. PubMed ID: 24287064
[TBL] [Abstract][Full Text] [Related]
8. Pharmacologically enhanced expression of GPNMB increases the sensitivity of melanoma cells to the CR011-vcMMAE antibody-drug conjugate.
Qian X; Mills E; Torgov M; LaRochelle WJ; Jeffers M
Mol Oncol; 2008 Jun; 2(1):81-93. PubMed ID: 19383330
[TBL] [Abstract][Full Text] [Related]
9. Improved melanoma survival at last! Ipilimumab and a paradigm shift for immunotherapy.
Gajewski TF
Pigment Cell Melanoma Res; 2010 Oct; 23(5):580-1. PubMed ID: 20609175
[No Abstract] [Full Text] [Related]
10. Ipilimumab: a promising immunotherapy for melanoma.
Thumar JR; Kluger HM
Oncology (Williston Park); 2010 Dec; 24(14):1280-8. PubMed ID: 21294471
[TBL] [Abstract][Full Text] [Related]
11. The use of an antibody drug conjugate, glembatumumab vedotin (CDX-011), for the treatment of breast cancer.
Keir CH; Vahdat LT
Expert Opin Biol Ther; 2012 Feb; 12(2):259-63. PubMed ID: 22229970
[TBL] [Abstract][Full Text] [Related]
12. [Radioimmunoconjugates: therapy of non-Hodgkin lymphomas and colorectal carcinomas].
Griesinger F; Trümper L; Becker W
Internist (Berl); 2001 Jun; 42(6):860-4, 866-73. PubMed ID: 11449633
[No Abstract] [Full Text] [Related]
13. Gpnmb/osteoactivin, an attractive target in cancer immunotherapy.
Zhou LT; Liu FY; Li Y; Peng YM; Liu YH; Li J
Neoplasma; 2012; 59(1):1-5. PubMed ID: 22017590
[TBL] [Abstract][Full Text] [Related]
14. Development and Integration of Antibody-Drug Conjugate in Non-Hodgkin Lymphoma.
Mehta A; Forero-Torres A
Curr Oncol Rep; 2015 Sep; 17(9):41. PubMed ID: 26194424
[TBL] [Abstract][Full Text] [Related]
15. Melanoma drug wins US approval.
Ledford H
Nature; 2011 Mar; 471(7340):561. PubMed ID: 21455150
[No Abstract] [Full Text] [Related]
16. [Immunoconjugates, drug-armed antibodies to fight against cancer].
Haeuw JF; Caussanel V; Beck A
Med Sci (Paris); 2009 Dec; 25(12):1046-52. PubMed ID: 20035677
[TBL] [Abstract][Full Text] [Related]
17. Immunoconjugates: lessons from animal models.
Canevari S; Colombatti M; Colnaghi MI
Ann Oncol; 1994 Oct; 5(8):698-701. PubMed ID: 7826901
[TBL] [Abstract][Full Text] [Related]
18. Dramatic Survival Benefit with Nivolumab in Melanoma.
Cancer Discov; 2016 Jun; 6(6):OF7. PubMed ID: 27091855
[TBL] [Abstract][Full Text] [Related]
19. Current uses of monoclonal antibodies in the treatment of acute leukemia.
Ruffner KL; Matthews DC
Semin Oncol; 2000 Oct; 27(5):531-9. PubMed ID: 11049021
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal antibodies in tumor therapy.
Matzku S
Recent Results Cancer Res; 1996; 141():1-8. PubMed ID: 8722416
[No Abstract] [Full Text] [Related]
[Next] [New Search]
